22
https://pubmed.ncbi.nlm.nih.gov/38113700
Pimavanserin reduces the risk of psychosis relapse in patients with Parkinson’s disease dementia (PDD) without worsening motor or cognitive function.
https://pubmed.ncbi.nlm.nih.gov/38113700
Pimavanserin reduces the risk of psychosis relapse in patients with Parkinson’s disease dementia (PDD) without worsening motor or cognitive function.